Helwan University
Clinical trials sponsored by Helwan University, explained in plain language.
-
Heart shield: diabetes drug may protect breast cancer patients from chemo damage
Disease control Recruiting nowThis study tests if dapagliflozin, a drug used for diabetes, can protect the heart from damage caused by anthracycline chemotherapy in breast cancer patients. Forty adults with breast cancer will take dapagliflozin or a placebo alongside their chemo. Researchers will measure hear…
Phase: PHASE4 • Sponsor: Helwan University • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
New sedation cocktail may protect elderly hearts during ICU breathing support
Symptom relief Recruiting nowThis study compares a combination of two sedatives (propofol and ketamine) against propofol alone in elderly ICU patients who need a breathing tube. The goal is to see if the combo reduces dangerous drops in blood pressure. About 41 patients aged 65 and older with heart disease a…
Phase: PHASE3 • Sponsor: Helwan University • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
New bendable tool may improve kidney stone surgery
Symptom relief Recruiting nowThis study tests whether a new bendable tube (sheath) used during kidney stone surgery is safer and more effective than the standard tube. About 100 adults with large, branching kidney stones will be randomly assigned to one of the two tools. The goal is to see which approach lea…
Phase: NA • Sponsor: Helwan University • Aim: Symptom relief
Last updated May 19, 2026 11:52 UTC